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ABSTRACT
The role of Tyr115 of human immunodeficiency virus
type 1 reverse transcriptase (HIV-1 RT) in the mispair
extension fidelity of DNA dependent DNA synthesis
was analysed by using a series of 15 mutant enzymes
with substitutions at Tyr115. Their kinetic parameters
for elongation using homopolymeric RNA–DNA and
heteropolymeric DNA–DNA complexes showed major
effects of the amino acid substitutions on the Km value
for dNTP. Enzymes with large hydrophobic residues at
position 115 displayed lower Km values than enzymes
with small and charged amino acids at this position.
The influence of all these amino acid replacements in
mispair extension fidelity assays was analyzed using
three different mismatches (A:C, A:G and A:A) at the
3′-terminal position of the primer DNA. For the A:C
mispair, a 2.6–33.4-fold increase in mispair extension
efficiency (fext) was observed as compared with the
wild-type enzyme. Unexpectedly, all the mutants tested
as well as the wild-type RT were very efficient in
extending the A:G and A:A transversion mispairs. This
effect was due to the template–primer sequence
context and not to the buffer conditions of the assay.
The data support a role of Tyr115 in accommodating
the complementary nucleotide into the nascent DNA
while polymerization takes place.
INTRODUCTION
During the retrovirus life cycle, the reverse transcriptase (RT)
replicates the viral genomic RNA to synthesize a double-stranded
DNA which integrates into the host genome. Reverse transcription
is error prone and contributes to the high genetic variability of
retroviruses. Mutation rates in a single cycle of retrotranscription
are in the range 10–4–10–5 misincorporations per nucleotide (1).
One of the consequences of the high mutation rates has been the
emergence of drug resistant HIV variants, which has become an
important obstacle in the control of AIDS. The HIV-1 RT is a
heterodimeric enzyme composed of two subunits of 66 and 51
kDa respectively (2,3). The catalytic properties of the enzyme
reside within the 66 kDa subunit. Studies with purified HIV-1 RT
have revealed an unusually high error rate in copying DNA or
RNA templates (4–9; reviewed in 10). Errors can be generated
either by direct misinsertion of an incorrect nucleotide or by
transient primer slippage (9,11–13). However, the molecular
mechanisms governing fidelity of DNA synthesis are largely
unknown. Site-directed mutagenesis studies on the HIV-1 RT
have provided some clues on the role of different amino acids in
fidelity of DNA synthesis. The substitution of Gly262 or Trp266
by Ala renders enzymes with decreased frameshift fidelity (14),
probably because these amino acids are involved in interactions
with the template–primer (15). Both residues are located within
α-helix H (residues 253–271) that together with α-helix I
(residues 277–287) form the ‘helix clamp’ at the thumb
subdomain of the 66 kDa subunit. Substitution of the other amino
acids found at these two helical regions did not have significant
effects on fidelity of DNA synthesis (15,16). Base substitution
errors could occur during DNA polymerization by a simple
two-step mechanism. It would involve the misinsertion of a
non-complementary base into the nascent DNA, followed by
extension of the 3′-terminal mismatch. The later step would fix
the incorporated mismatched nucleotide into the nascent DNA.
Nucleoside analog resistant mutants of HIV-1 RT, such as M184V
(17,18) or E89G (19) displayed a 1.4–17-fold increase in
insertion fidelity compared to the wild-type RT. A similar effect
was also reported for a variant RT with Leu instead of Met at
position 184 (20). This substitution, as well as the replacement of
Tyr183 by Phe, rendered enzymes with enhanced fidelity of
mispaired extension relative to wild-type RT (20). In contrast,
other amino acid changes led to enzymes whose fidelity of
mispair extension was either similar to that of wild-type RT, as in
mutants M184V, Y181I or Y188L (18,21), or somewhat reduced
as observed in the case of M184A (18) or the double mutant
C38S/C280S (22).
In a previous study, we described variant RTs with substitutions
of Tyr115 by Phe, Trp, Ala, Ser, Asp or Lys (23). While Y115F
showed a wild-type phenotype, the other RTs had either an
impaired dNTP binding function or were almost inactive. We also
showed that Tyr115 plays a role in misinsertion fidelity of DNA
synthesis, as judged by a nucleotide misinsertion assay (23). In
this report, we describe the preparation and purification of RTs,
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and report kinetic properties of dTTP binding for 16 RT variants.
The effects on the fidelity of mispair extension are also shown.
The comparison of frequencies of nucleotide misinsertion and
mismatch extension indicates that the mutator phenotype of most
of these enzymes is determined by the influence of Tyr115 in
dNTP recognition.
MATERIALS AND METHODS
Mutagenesis
Site-directed mutagenesis was carried out with the Altered Sites
in vitro mutagenesis system kit from Promega following the
manufacturer’s instructions. The single-stranded DNA (ssDNA)
template used in the mutagenesis reaction was obtained from
Escherichia coli DH5αF′ cultures harbouring a pALTER-derived
construct containing the coding sequence of the 66 kDa subunit
of HIV-1 RT (23). The RT mutations and the oligodeoxynucleotides
used in the mutagenesis reaction are shown in Table 1. Synthetic
oligonucleotides were obtained from Isogen Bioscience
(Maarssen, Holland). The introduced mutations were confirmed
by digestion with NsiI and by DNA sequencing. DNA fragments
containing the desired mutations were cloned in the p66(RT) and
pT51H expression vectors, as previously described (23).
Table 1. Synthetic oligonucleotides used in the mutagenesis of DNA encoding
HIV-1 RT
Mutationsa Oligonucleotideb
Y115V, Y115L 5′-GGGAACTGAAAAAASTGCATCACCCACATC-3′
Y115M, Y115I 5′-GGGAACTGAAAASATTGCATCACCCACATC-3′
Y115N, Y115H 5′-GGGAACTGAAAAATKTGCATCACCCAC-3′
Y115G, Y115C 5′-GGGAACTGAAAAACMTGCATCACCCACATC-3′
Y115P 5′-GGGAACTGAAAAAGGTGCATCACCCACATC-3′
aMutations are identified by the corresponding amino acid position in HIV-1 RT,
followed by the substituted amino acid. Amino acids are denoted by the single-
letter code.
bUnderlined nucleotides correspond to mutations introduced in the RT coding
region. Several mutants were obtained with oligonucleotide mixtures: S stands
for C+G, K for T+G and M for A+C. All the introduced mutations except for
Y115C lead to the loss of an NsiI restriction site.
Expression and purification of HIV-1 RT variants
Purification of mutant and wild-type RTs was carried out after
independent expression of their subunits, by following a previously
described procedure (23). The 51 kDa subunit was obtained with
an extension of 14 amino acid residues at its N-terminal end,
which includes six consecutive histidines to facilitate its purification
by metal chelate affinity chromatography. In this study, amino
acid substitutions were introduced in both subunits of the RT. The
purity of the enzymes was assessed by SDS–PAGE. All enzymes
were ≥95% pure. RT concentrations were determined using the
BioRad protein assay.
DNA polymerase activity assays
DNA polymerase activity of the purified RTs and their steady
state kinetic parameters were obtained as previously described,
assuming that 50% of the enzyme was active as determined by
active site titration (23). The assay solution contained 50 mM
Tris–HCl, pH 8.0, 20 mM NaCl, 10 mM MgCl2, 8 mM
dithiothreitol, 3–5 µCi/ml [3H]dTTP and 1 µM poly(rA)·
oligo(dT)20 (concentration expressed as 3′-hydroxyl primer
termini). For the determination of kinetic parameters, the dTTP
concentration was adjusted with non-radioactive nucleotide, and
ranged from 1 µM to 3.6 mM depending on the enzyme tested.
Reactions (30 µl) were initiated by the addition of 0.8–10 pmol
enzyme, incubated at 37C for 10–30 min and terminated by
adding 20 µl 0.5 M EDTA. After addition of 6 µl 0.5 mg/ml
salmon sperm DNA and 600 µl cold 10% trichloroacetic acid
(TCA) in 20 mM sodium pyrophosphate, samples were kept on ice
for 20–30 min. The TCA-precipitable materials were collected on
Whatman GF/A filters and counted for radioactivity in a liquid
scintillation counter.
RNase H activity assays
Assays were done in buffer containing 25 mM Tris–HCl, pH 8.5,
5 mM MgCl2, 1.5% glycerol, 50 µg/ml bovine serum albumin,
0.01% Nonidet P-40 and 2 µCi/ml [3H]poly(rA)·poly(dT) (24).
The RNase H substrate was prepared by mixing 10 µCi
[3H]poly(rA) in 0.5 ml distilled water, with 0.53 ml (dT)221
containing 0.5 A260 U/ml. The mixture was incubated at 70C for
5 min, slowly cooled at room temperature, and stored in 100 µl
aliquots at –20C until use. The enzyme concentration in these
assays was around 100–150 nM. Samples (100–120 µl) were
incubated at 37C for 5–30 min. At different times, 25 µl aliquots
were taken and reactions were terminated by addition of 5 µl
salmon sperm DNA (0.5 mg/ml) and 85 µl cold 10% TCA in
20 mM sodium pyrophosphate. Samples were kept on ice for 10 min
and centrifuged 10 min at 12000 r.p.m. The supernatants (80 µl)
were diluted in 3 ml Optiphase ‘Hisafe’ scintillation fluid
(Wallac, Turku, Finland) and counted for radioactivity in a liquid
scintillation counter.
Mispair extension fidelity assays
Assays were performed essentially as described (25) with the
modifications introduced by Martín-Hernández et al. (23).
Template–primers used in these assays are shown in Figure 1. The
template D2 and the complementary 16mer primers were taken
from Ricchetti and Buc (26). D2 is a 38mer mimicking the HIV-1
gag sequence and includes nucleotides 1137 (5′ end)–1174 (3′
end), according to the sequence numbering of Ratner et al. (27).
M13mp2 was grown in the E.coli NR9099 strain and template
M13 ssDNA was prepared as described (28). The oligonucleo-
tides used for mispair extension assays in which M13 ssDNA was
used as template were those described by Mendelman et al. (29)
and correspond to positions 5386–5405 of the M13 genome (30).
The oligonucleotides used in these experiments were from
Pharmacia (D2 and PG5), Isogen Bioscience (PG5C and PG5G)
and Gibco BRL (PG5A, pT, pC and pG). Primer 5′ termini were
labelled with [γ-32P]ATP (10 mCi/ml, Amersham) and T4
polynucleotide kinase (Boehringer). The templates and the
corresponding 32P-labelled primers were annealed in 150 mM
NaCl and 150 mM magnesium aspartate for 3 min at 90C.
Samples were then cooled slowly to room temperature. The
template–primer concentration ratio was adjusted to 1:1, equivalent
to a 3 µM final concentration in the hybridization solution. Prior
to the elongation reaction assay, the DNA duplexes were diluted
10-fold in 500 mM HEPES, pH 7.0, 150 mM NaCl and 150 mM
magnesium aspartate (final concentrations). Steady state kinetics
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were performed in 50 mM HEPES, pH 7.0, 15 mM NaCl, 15 mM
magnesium aspartate, 130 mM KCH3COO, 1 mM dithiothreitol
and 5% polyethylene glycol 6000. The reaction volume was 20 µl
and the enzyme concentration in these assays was ∼6 nM. The
molar ratio of template–primer to enzyme in the reaction mixture
was estimated to be 5:1 in assays with the D2 template and the
PG5 primers, and 2.5:1 in those assays performed using M13
ssDNA. The reaction was initiated by first equilibrating the RT
with the annealed template–primer in the absence of dNTPs (10 min
at 37C), followed by the addition of appropriate dNTPs at
various concentrations. The reaction was carried out for 30 s at
37C, and then stopped by addition of 8 µl 10 mM EDTA in 90%
formamide containing 3 mg/ml xylene cyanol FF and 3 mg/ml
bromophenol blue. Samples were denatured at 80C for 5 min,
cooled on ice and 4 µl aliquots were loaded on a 20%
polyacrylamide gel (35 × 42 × 0.04 cm), containing 8 M urea. The
samples were electrophoresed for 4–6 h at 65 W (∼2000 V) to
obtain good resolution of extended primers. Autoradiography of
samples labelled with 32P was performed by exposing gels to
photostimulable imaging plates (Fujifilm BAS-MP 2040S).
Radioactive band intensities were measured in a Fujifilm
Bio-imaging analyser BAS-1500, using the program Tina version
2.09 (Raytest Isotopenmessgerate GmbH, Staubenhardt, Germany).
Elongation measurements were fitted to the Michaelis–Menten
equation using the UltraFit Macintosh program (version 1.03;
Biosoft). Primer degradation was estimated to be very small in
control reactions performed in the absence of dNTP, indicating
that the purified RTs were free of contaminating nuclease activity.
Table 2. Kinetic parameters for dTTP binding of wild-type and mutant RTsa
Enzymes Km kcat kcat/Km 
(µM) (s–1) (mM–1s–1)
WTb 6.7 ± 1.7 0.47 ± 0.16 70.1 ± 10.8
Y115Fb 3.0 ± 1.0 0.23 ± 0.10 76.7 ± 17.8
Y115I 52.8 ± 7.2 1.28 ± 0.22 24.2 ± 1.0
Y115V 62.7 ± 14.8 1.12 ± 0.17 18.3 ± 3.9
Y115Wb 44.8 ± 7.7 0.51 ± 0.02 11.4 ± 2.0
Y115M 92.9 ± 11.6 0.94 ± 0.25 10.0 ± 1.8
Y115N 116.2 ± 21.0 0.70 ± 0.09 6.2 ± 1.8
Y115C 133.9 ± 28.3 0.71 ± 0.11 5.5 ± 1.6
Y115L 177.9 ± 32.4 0.60 ± 0.17 3.6 ± 1.5
Y115Ab 156.7 ± 19.9 0.50 ± 0.05 3.2 ± 0.9
Y115Sb 235.2 ± 26.4 0.65 ± 0.05 2.8 ± 0.4
Y115H 166.8 ± 26.7 0.43 ± 0.11 2.0 ± 0.5
Y115G 566.0 ± 75.0 0.65 ± 0.23 0.9 ± 0.2
aPoly(rA)484·oligo(dT)20 was used as substrate. The template–primer nucleotide
ratio was 10:1 (approximate molar ratio 1:2.5). Mutants Y115D, Y115K and
Y115P showed negligible activity (kcat < 0.005 s–1). Data shown are the mean va-
lues ± standard deviation, obtained from a non-linear least squares fit of the kin-
etics data to the Michaelis–Menten equation. Each of the experiments was
performed independently at least twice.
bReported data for this enzyme were taken from ref. 23.
RESULTS
Effect of amino acid substitutions on dTTP binding
Steady state kinetic analysis of polymerization by wild-type and
mutant RTs was performed with poly(rA)·oligo(dT)20 and dTTP.
As shown in Table 2, substitution of Tyr115 often renders a variant
Figure 1. Nucleotide sequence of the template–primer complexes used in the
mispair extension fidelity assays. Kinetic parameters of extension were
measured as a function of the concentration of the next correct nucleotide: dTTP
for D2-containing template–primers, and dATP for the complexes formed with
the M13 ssDNA template. Underlined nucleotides in the primer sequence
indicate the mismatch. Incorporation sites are indicated with an asterisk.
enzyme with lower affinity for dTTP than the wild-type enzyme,
in agreement with our previously published observations (23).
kcat values were not largely affected by replacements at Tyr115.
The Km values for dTTP binding ranged from 3.0 µM (as in
Y115F, the only variant enzyme tested which displayed a similar
or slightly increased affinity for dTTP) to 566 µM, as observed
for Y115G. The size and hydrophobicity of the amino acid
occupying position 115 are apparently important to maintain the
low Km value. The substitution of Tyr115 by small non-hydrophobic
amino acids resulted in a dramatic increase of the Km for dTTP.
The kcat/Km values were generally higher for variants with
hydrophobic residues at position 115. RNase H activity assays
performed with RTs having Ile, Val, Met, Asn, Cys, Ala, His, Gly
or Pro at position 115 failed to reveal any significant differences
in specific activity among them and the wild-type RT. Their
average RNase H specific activity was 324.4 ± 57.4 U/mg (1 unit
is defined as 1 nmol [3H]adenylate produced in 1 h at 37C).
Interestingly, mutant Y115P, which was devoid of DNA polymerase
activity (Table 2), showed nevertheless normal RNase H activity
(data not shown).
Mispair extension fidelity
The kinetics of mispair extension were studied for correctly
matched base pairs (A:T) and for mismatches A:C, A:G and A:A.
The sequences of template–primers used in these assays are given
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Figure 2. Mispair extension efficiency of mismatch A:C of wild-type and
mutant HIV-1 RTs. Represented values were calculated from Table 3 as the ratio
between the mispair extension efficiency (fext) of each enzyme relative to the
wild-type RT.
in Figure 1. Steady state parameters for the incorporation of dTTP
at the matched 3′ terminus (A:T) were largely affected by
non-conservative substitutions of Tyr115 (Table 3), as observed
in assays using homopolymeric RNA–DNA template primers
(Table 2). Thus, the Km for dTTP was 180 nM for the wild-type
RT and ranged from 52 nM (Y115F) to 215 µM (Y115G). Lower
Km values are usually associated to enzymes with larger
hydrophobic residues at position 115. The extension of mismatch
A:C proceeds at a similar rate to the extension of the matched 3′
terminus (A:T) for all mutant enzymes. Thus, the ratio between
the corresponding Vmax is 1.03 for the wild-type RT and ranges
from 0.31 (Y115L) to 1.66 (Y115C). The effects on the Km values
are more pronounced. Thus, wild-type RT shows a Km for the
incorporation of dTTP at the 3′ end of the mismatch A:C which
is 122.8 times higher than at the 3′ end of the matched A:T pair.
In contrast, this ratio is significantly lower in many of the
described mutants (e.g. 2.85 for Y115L or 4.3 for Y115G).
Therefore, differences in mispair extension fidelity of these
mutants are mainly determined by the Km values. The mispair
extension efficiencies of all the mutants relative to the wild-type
RT are compared in Figure 2. This comparison reveals that in all
cases, fidelity decreases when Tyr115 is substituted by another
amino acid. The substitution of Tyr115 by Phe or other bulky
hydrophobic amino acids renders enzymes which extend the A:C
mismatch only 3–4 times better than the wild-type RT. In contrast,
the replacement of Tyr115 by small residues such as Gly or Ser,
or by charged amino acids like His leads to enzymes with low
mispair extension fidelity. An exception to this general trend is
observed with Y115L, which is about 13 times more efficient than
the wild-type RT in extending the A:C mismatch. This behaviour
could not be attributed to additional mutations in the RT coding
sequence, as confirmed by DNA sequencing.
Table 3. Kinetic constants of mismatch extension for wild type and mutant
HIV-1 RTs using D2-containing template–primersa 
Enzymes Pair Km Vmax Vmax/Km fextb
(µM) (nM/min) (min–1)
WT A:Tc 0.18 ± 0.01 17.8 ± 2.0 0.104
A:C 22.1 ± 4.4 18.3 ±0.9 8.3 × 10–4 0.008
A:G 0.13 ± 0.04 1.36 ± 0.30 1.05 × 10–2 0.101
A:A 0.14 ± 0.03 2.30 ± 0.09 1.6 × 10–2 0.154
Y115F A:Tc 0.05 ± 0.001 13.8 ± 0.4 0.266
A:C 3.5 ± 0.6 19.9 ± 0.9 5.7 × 10–3 0.021
A:G 0.04 ± 0.02 0.74 ± 0.03 1.9 × 10–2 0.071
A:A 0.05 ± 0.01 1.82 ± 0.09 3.6 × 10–2 0.135
Y115I A:T 27.0 ± 2.6 17.1 ± 0.3 6.3 × 10–4
A:C 693 ± 119 13.4 ± 0.75 1.9 × 10–5 0.03
A:G ND ND ND ND
A:A ND ND ND ND
Y115V A:T 9.0 ± 1.1 12.1 ± 0.3 1.3 × 10–3
A:C 355 ± 76 14.9 ± 0.9 4.2 x 10–5 0.032
A:G 1.01 ± 0.70 0.36 ± 0.01 3.6 × 10–4 0.277
A:A 5.0 ± 1.2 2.03 ± 0.07 4.1 × 10–4 0.315
Y115W A:T c 9.7 ±1.6 12.2 ± 1.0 1.3 × 10–3
A:C 425 ± 98 15.1 ± 1.1 3.5 × 10–5 0.027
A:G 12.3 ± 2.3 1.04 ± 0.04 8.4 × 10–5 0.065
A:A 9.6 ± 5.0 2.13 ± 0.20 2.2 × 10–4 0.169
Y115M A:T 31.6 ± 4.6 20.0 ±0.6 6.3 × 10–4
A:C 587 ± 141 9.03 ± 0.70 1.5 × 10–5 0.024
A:G ND ND ND ND
A:A ND ND ND ND
Y115N A:T 13.0 ± 1.2 17.8 ± 0.3 1.4 × 10–3
A:C 133 ± 18 26.6 ± 0.8 2.0 × 10–4 0.143
A:G ND ND ND ND
A:A ND ND ND ND
Y115C A:T 20.7 ± 3.9 14.0 ± 0.6 6.8 × 10–4
A:C 407 ± 67 23.2 ± 1.2 5.7 × 10–5 0.084
A:G 5.5 ± 2.2 0.35 ± 0.03 6.4 × 10–5 0.094
A:A 11.3 ± 3.2 1.7 ± 0.08 1.5 × 10–4 0.220
Y115L A:T 92.5 ± 12.0 17.4 ± 0.5 1.9 × 10–4
A:C 264 ± 80 5.45 ± 0.55 2.0 × 10–5 0.105
A:G ND ND ND ND
A:A ND ND ND ND
Y115A A:T c 29.3 ± 4.6 21.0 ± 1.5 7.2 × 10–4
A:C 475 ± 133 11.8 ± 1.2 2.5 × 10–5 0.035
A:G 43.4 ± 19.0 0.80 ± 0.05 1.8 × 10–5 0.025
A:A 44.5 ± 12.0 1.70 ± 0.09 3.8 × 10–5 0.053
Y115S A:T c 66.7 ± 9.0 16.1 ±0.9 2.4 × 10–4
A:C 428 ± 50 18.6 ± 0.7 4.3 × 10–5 0.179
A:G 79.5 ± 7.3 2.04 ± 0.03 2.6 × 10–5 0.108
A:A 49.3 ± 6.5 2.37 ± 0.07 4.8 × 10–5 0.2
Y115H A:T 57.8 ± 12.5 15.0 ± 0.8 2.6 × 10–4
A:C 861 ± 141 14.7 ± 0.9 1.7 × 10–5 0.065
A:G ND ND ND ND
A:A ND ND ND ND
Y115G A:T 215 ± 25 19.6 ± 0.7 9.0 × 10–5
A:C 927 ± 115 22.4 ± 1.0 2.4 × 10–5 0.267
A:G 60.8 ± 19.0 0.50 ± 0.05 8.0 × 10–6 0.089
A:A 90.3 ± 24.2 2.25 ± 0.11 2.5 × 10–5 0.277
aThe template–primer complexes used as substrates in this experiment are given
in Figure 1. Data shown represent the average values ± standard deviations
obtained as indicated in Table 2.
bfext = [Vmax (mismatched)/Km (mismatched)]/[Vmax (matched)/Km (matched)].
cThese data were taken from ref. 23.
ND, Not determined.
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Table 4. Kinetic constants of mismatch extension for wild type and mutant HIV-1 RTs using an M13 ssDNA templatea 
Enzymes Pair Km Vmax Vmax/Km fextb fext (mut)/fext (wt)
(µM) (nM/min) (min–1)
WT A:T 0.08 ± 0.03 7.34 ± 0.46 0.092
A:C 30.1 ± 5.8 3.91 ± 0.18 1.3 × 10–4 1.4 × 10–3
A:G 350 ± 74 0.94 ± 0.10 2.7 × 10–6 2.9 × 10–5
Y115V A:T 0.69 ± 0.15 7.05 ± 0.67 0.010
A:C 56.7 ± 16.8 3.79 ± 0.86 6.7 × 10–5 6.5 × 10–3  4.6
Y115W A:T 11.8 ± 1.5 9.67 ± 1.34 8.2 × 10–4
A:C 442 ± 67 4.12 ± 0.85 9.3 × 10–6 0.011  8.0
Y115S A:T 9.3 ± 3.0 7.00 ± 0.60 7.5 × 10–4
A:C 133 ± 36 3.56 ± 0.70 2.7 × 10–5 0.036 25.3
Y115G A:T 19.6 ± 4.8 9.03 ± 1.02 4.6 × 10–4
A:C 217 ± 40 4.92 ± 1.00 2.2 × 10–5 0.049 34.9
aNucleotide sequences of the template–primer complexes used are given in Figure 1. Data shown represent the average values ± standard deviations
obtained as indicated in Table 2.
bfext is defined as in Table 3.
Transversion mispairs such as A:G or A:A were extended at a
lower rate than the A:T pairs. Thus, extension of the A:G
mismatch proceeds at a Vmax, which is 7.9–40 times slower than
for the correctly matched A:T. For the A:A mismatch, the Vmax
is 5.7–12.4 times smaller than for A:T. Surprisingly, the Km for
extension of purine:purine mispairs was almost the same as for
A:T pairs, producing relative extension frequencies of around 0.1.
In those circumstances it was not possible to observe any increase
in relative extension efficiencies in the assayed mutants. These
results imply that HIV-1 RT may extend transversion mispairs
with high efficiency and that discrimination between correctly or
incorrectly matched template–primer is primarily directed by the
Vmax, at least in our assay conditions. In order to determine if this
observation was limited to the particular sequence context of the
D2/PG5 template–primer used, we performed mispair extension
fidelity assays using different template–primers. M13 ssDNA
was used as template and oligonucleotides of 20 residues having
T, G or C opposite to A at the 3′ end as primers (Fig. 1). The
experiments were performed using wild-type HIV-1 RT in our
assay conditions (23,25). The results are shown in Table 4. In the
M13 sequence context the Km for the extension of the A:G
mispair increases with respect to that of the A:T pair by a factor
>103, and this difference in Km is the determinant of the poor
extension efficiency of this mismatch in this sequence context. In
contrast, the extension efficiency of the A:C mispair was roughly
similar to that observed with the D2/PG5 duplexes (1.4 × 10–3 and
8.0 × 10–3 respectively). The A:C mispair extension efficiency in
the M13 sequence context was also determined for mutants
Y115W, Y115V, Y115S and Y115G (Table 4). Interestingly, their
A:C mispair extension efficiencies (fext) relative to the wild-type
HIV-1 RT were higher for Y115G and Y115S and lower for
Y115V and Y115W, in agreement with the results obtained with
the D2/PG5 template–primers.
DISCUSSION
Tyr115 is located in the vicinity of the triad of aspartyl groups
forming the catalytic site of HIV-1 RT (2,3). The importance of
this residue for polymerase activity was suggested from assays
performed using bacterial extracts containing variant enzymes
with substitutions at Tyr115. Thus, the replacement of Tyr by Phe
or Val rendered enzymes with similar activity to the wild-type RT
(31–33). In contrast, the polymerase activity of enzymes having
Asn or His instead of Tyr115 was estimated as <15% of that
reported for wild-type RT (31). Our published results (23) and
those described in this paper are consistent with these observa-
tions. Amino acid changes involving Tyr115 have a dramatic
effect on the binding affinity of dNTP. For example, the Km for
dTTP was 84.4 times higher for Y115G than for the wild-type RT
when poly(rA)·oligo(dT)20 was used as template–primer. Other
amino acid replacements affecting residues of the putative dNTP
binding site of HIV-1 RT (e.g. the substitution of Gln151 or
Met184 by Ala) also produce an increase in the Km values for
dTTP when poly(rA)·oligo(dT) is used as template–primer
(18,34,35). Our previously reported data showed that all mutants
including the poorly active Y115D and Y115K had normal DNA
binding affinity (23). We have now described another mutant
(Y115P) which was devoid of polymerase activity, although it
showed the same RNase H specific activity as the wild-type RT.
Taken together, the results of DNA binding experiments and
RNase H assays suggest that the RT variants are correctly folded.
The kinetic parameters governing incorporation of nucleotides
into correctly matched DNA–DNA template–primers correlate
well with those obtained with homopolymeric RNA–DNA
complexes. In both cases, HIV-1 RT variants with bulky
hydrophobic residues at position 115 show higher affinity for
dTTP than those having small or charged amino acids. Results of
mispair extension efficiency for mismatch A:C revealed a similar
trend to the kinetic measurements. Although all mutants extend
the mismatch A:C at a higher rate than the wild-type RT, the
effects were more pronounced when smaller and less hydro-
phobic residues were found at position 115.
Retroviral reverse transcriptases exhibit a higher mismatch
extension (fext)/nucleotide insertion (fins) ratio than eukaryotic
DNA polymerases (29). Extension of mismatched 3′ termini of
DNA has been shown to be a major determinant of the infidelity
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of HIV-1 RT (11). Our data on mispair extension fidelity are in
agreement with those observations. In our assays, the fext value for
the wild-type enzyme ranges from 8 × 10–3 to 0.154, while fins
was reported to be 1.54 × 10–5 (23). Substitutions involving
Tyr115 have a major effect on the misinsertion fidelity of DNA
synthesis. Thus, the nucleotide misinsertion efficiency (fins) of
mutants Y115S, Y115A and Y115W is 590.9, 188.3 and 64.9
times higher respectively compared with wild-type RT. However,
the efficiency of mismatch extension (fext) for the same mutants
is only 22.5, 4.4 and 3.4 times higher for mismatch A:C, and
roughly similar to wild-type RT, when mispairs A:G or A:A are
considered. Therefore, Tyr115 appears to play a more determinant
role in recognition of the correct nucleotide than in its further
extension, in agreement with our views on its role in dNTP
binding (23). Patel et al. (36) suggested that Tyr115 may interact
directly by hydrophobic forces with the base of the incoming
nucleotide. Molecular modeling of an incoming dNTP suggests
that the triad of aspartic acid residues of the active site interact
with the phosphates, while several amino acids forming the
fingers, thumb and palm subdomains of the 66 kDa subunit,
would position the template–primer in an appropriate manner for
catalysis. In this scenario, the enzyme suffers a conformational
change that positions the dNTP in the right conformation for the
nucleophilic attack by the 3′ OH of the primer (36,37). If the
nucleotide at the 3′ OH of the primer is not correctly paired with
the corresponding base in the template, the 3′ OH may not be
correctly positioned, and the conformational change may not
facilitate the correct alignment for the interaction between the
α-phosphate of the incoming dNTP and the 3′ OH of the primer.
The consequence would be that the enzyme would lose affinity
for the next nucleotide. Mutants of Tyr115 could, in some way,
accommodate better than the wild-type the bulged mismatch, and
do so more easily when the residue at position 115 is less
hydrophobic and smaller than Tyr. In this case, the mutant RTs
could lose less affinity for the next dNTP than the wild-type RT,
thus extending the mismatch more easily with the result of a
decreased fidelity.
In our assays, purine–purine mismatches were extended very
efficiently even by wild-type RT (fext ≈ 0.1–0.2). This is
surprising in view of previous studies with HIV-1 RT and other
polymerases, which indicated that these kinds of mismatches are
poorly extended, with relative extension frequencies around
10–4–10–5 (11,13,20,22,29,38). Base context appears to be
important for the relative stability of base mispairs (29,39). When
the template–primer complexes used by Mendelman et al. (29)
were assayed with the wild-type HIV-1 RT in the buffer conditions
of our assay, we obtained a relative extension frequency of 2.9 ×
10–5 for the A:G mispair. This result further confirms the extreme
dependence of fidelity on sequence context (12). Interestingly, in
the case of the A:C mispair, the extension efficiency of the
wild-type HIV-1 RT was similar with the M13-based duplexes
than with the D2-containing template–primers. Furthermore, the
effects of substitutions involving Tyr115 seemed to follow a
similar trend with both template–primers, suggesting that the
results obtained are representative of the behaviour of these
mutants.
Resistance mutations affecting Tyr115 are rarely found. Only
Phe has been reported to appear at this position after passage of
the virus in the presence of the nucleoside analog RT inhibitor
1592U89 (40). Our data indicate that this substitution does not
have a significant influence on fidelity of DNA-dependent DNA
synthesis. The mutator phenotype as well as the low polymerase
activity of the other HIV-1 RT variants could explain why these
mutations are not found in vivo. High mutation rates caused by
inaccurate reverse transcription may interfere with the coding
ability of the genome and ultimately cause deterioration of the
quasispecies (41,42). In this context, mutator RTs can be useful
tools to study the molecular mechanisms of fidelity of DNA
synthesis, and an aid leading to the design of antiretroviral drugs
targeting the fidelity properties of the RT.
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